Cargando…

Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors

Aim: In percutaneous coronary intervention (PCI)-treated acute coronary syndrome (ACS) patients on clopidogrel therapy, high on-treatment platelet adenosine diphosphate (ADP) reactivity was observed in numerous studies, with significant increases in non-fatal myocardial infarction, definite/probable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ristorto, Jessica, Messas, Nathan, Marchandot, Benjamin, Kibler, Marion, Hess, Sébastien, Meyer, Nicolas, Schaeffer, Michael, Tuzin, Nicolas, Ohlmann, Patrick, Jesel, Laurence, Morel, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099071/ https://www.ncbi.nlm.nih.gov/pubmed/29415954 http://dx.doi.org/10.5551/jat.40584

Ejemplares similares

Impact of Opioid Analgesia and Inhalation Sedation Kalinox on Pain and Radial Artery Spasm during Transradial Coronary Angiography
por: Birgy, Caroline, et al.
Publicado: (2020)

Prognostic Value of Incomplete Revascularization after Percutaneous Coronary Intervention Following Acute Coronary Syndrome: Focus on CKD Patients
por: Cardi, Thomas, et al.
Publicado: (2019)

Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study
por: Muller, Clotilde, et al.
Publicado: (2016)

Impact of Incomplete Coronary Revascularization on Late Ischemic and Bleeding Events after Transcatheter Aortic Valve Replacement
por: Carmona, Adrien, et al.
Publicado: (2020)

Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease
por: Zhang, Yan-Jiao, et al.
Publicado: (2022)

Impact of COVID-19 on the Cardiovascular System: A Review
por: Matsushita, Kensuke, et al.
Publicado: (2020)

Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement
por: Trimaille, Antonin, et al.
Publicado: (2021)

Personalized antiplatelet therapy with P2Y(12) receptor inhibitors: benefits and pitfalls
por: Winter, Max-Paul, et al.
Publicado: (2015)

Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch
por: Matsushita, Kensuke, et al.
Publicado: (2023)

Impact of Antithrombotic Regimen and Platelet Inhibition Extent on Leaflet Thrombosis Detected by Cardiac MDCT after Transcatheter Aortic Valve Replacement
por: Jimenez, Charline, et al.
Publicado: (2019)

Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y(1) and the P2Y(12) receptor and is correlated with protein expression of P2Y(12)
por: Braun, Oscar Ö, et al.
Publicado: (2006)

P2Y(12) Receptor Antagonist Clopidogrel Attenuates Lung Inflammation Triggered by Silica Particles
por: Santana, Patricia Teixeira, et al.
Publicado: (2020)

Increased susceptibility to SARS‐CoV‐2 infection in patients with reduced left ventricular ejection fraction
por: Matsushita, Kensuke, et al.
Publicado: (2020)

Combination of Primary Hemostatic Disorders and Atrial Fibrillation Increases Bleeding Events Following Transcatheter Aortic Valve Replacement
por: Matsushita, Kensuke, et al.
Publicado: (2023)

Value of Cardiac Biomarkers in the Early Diagnosis of Takotsubo Syndrome
por: Dagrenat, Charlotte, et al.
Publicado: (2020)

The Efficacy of P2Y12 Reactive Unit to Predict the Periprocedural Thromboembolic and Hemorrhagic Complications According to Clopidogrel Responsiveness and Safety of Modification of Dual Antiplatelet Therapy : A Meta-Analysis
por: Kim, Hyun Jung, et al.
Publicado: (2020)

P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients
por: Jørgensen, Niklas R., et al.
Publicado: (2017)

Correlation P2Y12 Genetic Polymorphism As Risk Factor of Clopidogrel Resistance in Indonesian Stroke Patients
por: Hidayat, Rakhmad, et al.
Publicado: (2023)

Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway
por: Guan, Baoyi, et al.
Publicado: (2022)

Dual Antiplatelet Therapy with Parenteral P2Y(12) Inhibitors: Rationale, Evidence, and Future Directions
por: Alagna, Giulia, et al.
Publicado: (2023)

Acute kidney injury and acute kidney recovery following Transcatheter Aortic Valve Replacement
por: Peillex, Marilou, et al.
Publicado: (2021)

High-grade atrioventricular block occurring during percutaneous closure of patent foramen ovale: a case report
por: Kibler, Marion, et al.
Publicado: (2020)

Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR
por: Dietrich, Laurent, et al.
Publicado: (2021)

Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome
por: Luo, Li-Man, et al.
Publicado: (2020)

Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

Progression of left anterior descending artery dissection due to stent implantation for spontaneous coronary artery dissection of left circumflex artery: a case report
por: Matsushita, Kensuke, et al.
Publicado: (2019)

Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y(12) inhibitors
por: Mazzeffi, Michael A., et al.
Publicado: (2017)

Influence of GAS5/MicroRNA‐223‐3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease
por: Liu, Yan‐Ling, et al.
Publicado: (2021)

Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic
por: Matsushita, Kensuke, et al.
Publicado: (2020)

Impact of Covid-19 infection in high-risk coronary patients
por: Carmona, A., et al.
Publicado: (2021)

Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients
por: Su, Jia, et al.
Publicado: (2014)

Electrocardiographic Strain Pattern Is a Major Determinant of Rehospitalization for Heart Failure After Transcatheter Aortic Valve Replacement
por: Heger, Joé, et al.
Publicado: (2021)

Antiplatelet Activity, P2Y(1) and P2Y(12) Inhibition, and Metabolism in Plasma of Stereoisomers of Diadenosine 5′,5′″-P(1),P(4)-dithio-P(2),P(3)-chloromethylenetetraphosphate
por: Chang, Hung, et al.
Publicado: (2014)

Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel
por: KIRKBY, N S, et al.
Publicado: (2011)

Short-Term Effects of Air Pollution on Coronary Events in Strasbourg, France—Importance of Seasonal Variations
por: Vaudrey, Baptiste, et al.
Publicado: (2020)

Third Generation P2Y(12) Inhibition for East Asian ACS Patients: Are We Really Different?
por: Keh, Yann Shan, et al.
Publicado: (2022)

P2Y(12) Inhibition beyond Thrombosis: Effects on Inflammation
por: Mansour, Alexandre, et al.
Publicado: (2020)

Omega-3 Fatty Acid Ethyl Esters do not Improve Clopidogrel Associated P2Y12 Inhibition in Stroke Patients
por: Li, Ping, et al.
Publicado: (2015)

Early clinical outcomes as a function of use of newer oral P2Y(12) inhibitors versus clopidogrel in the EUROMAX trial
por: Huber, Kurt, et al.
Publicado: (2017)

Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review
por: Tsuchida, Rikuhei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2vgiielja88h0g98jksnb4suut